Circadia Ventures focuses on investments in novel food ingredients, fine chemicals, fuels and next generation materials derived from renewable bio-resources, addressing global trends towards health, wellness and bio-based cleantech.
Circadia aims to make equity investments in privately owned companies with strong, defensible technology platforms and management teams whose ambition is to build aggressive high-growth businesses that deliver an exit for investors within three to five years.
We target ventures that are able to achieve commercialisation of their first products in large and growing markets within a two-year time-frame. This ‘early to market’ approach sits at the core of our investment strategy.
Circadia Ventures is the manager of Tate & Lyle Ventures LP, a £25m venture capital fund backed by Tate & Lyle PLC, one of the world's leading renewable ingredients companies focused on innovation and product development in these sectors. For further details of the fund, please click on the logo opposite.